Alwy Joseph, M V Prathvi, Roshiny Thankam James

A Review Article on Safety and Efficacy of Newer Oral Anticoagulants in the Treatment of Cerebral Venous Sinus Thrombosis

  • General Mathematics
Save to CiteDrive Show PDF

CVST (Cerebral Venous Sinus thrombosis) is an uncommon and complex illness with gender-specific origins and a wide range of clinical manifestations. It is also a rare kind of stroke that can be lethal if misdiagnosed or treated late. The reasons for this vary across industrialized and developing countries. It is distinguished by a clinical spectrum that is very varied, difficult diagnosis, various etiologies, and a prognosis that necessitates exceptional medical skills and a high suspicious score. When compared to vitamin K antagonists, NOACs had a roughly 50% decreased incidence of intracerebral hemorrhage. Direct oral anticoagulants have been the first-line medications used to treat this illness, but in this expanding world, newer oral anticoagulants such as Apixaban, Dabigatran, Rivaroxaban, and Edoxaban are being employed. Keywords: Cerebral venous Sinus Thrombosis, Newer oral anticoagulants, Factor X A, Apixaban, Dabigatran, Rivaroxaban, Edoxaban

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

  • Web-based, modern reference management
  • Collaborate and share with fellow researchers
  • Integration with Overleaf
  • Comprehensive BibTeX/BibLaTeX support
  • Save articles and websites directly from your browser
  • Search for new articles from a database of tens of millions of references
Try out CiteDrive

More from our Archive